Heat Biologics, Inc. (HTBX) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

Revenue by Geography

Revenue, Gross Profit, Operating and Net Income

RevenueGross ProfitOperating IncomeNet Income
02T5T8T10T12T15T18T20TQ1 2022Q4 2024Q1 2025Q2 2025Q3 2025

Margin (%)

Gross MarginOperating MarginNet Income Margin
02505007501K1K2K2K2KQ1 2022Q4 2024Q1 2025Q2 2025Q3 2025

Operating Expenses

Research And Development ExpensesSelling General And Administrative ExpensesOther Expenses
06T12T19T25T31T38T44T50TQ1 2022Q4 2024Q1 2025Q2 2025Q3 2025

EBITDA

EBITDA
-7T-6T-4T-3T-2T-750B500B2T3TQ1 2022Q4 2024Q1 2025Q2 2025Q3 2025

EPS

Revenue Variation (%)

Revenue Variation
-200500M1000M1B2B2B3B3B4BQ1 2022Q4 2024Q1 2025Q2 2025Q3 2025

Income Variation (%)

Gross Profit VariationOperating Income VariationNet Income Variation
0375M750M1B2B2B2B3B3BQ1 2022Q4 2024Q1 2025Q2 2025Q3 2025

Revenue YoY Variation (%)

Revenue YoY Variation
-80M180M440M700M960M1B1B2B2BQ1 2022Q4 2024Q1 2025Q2 2025Q3 2025

Income YoY Variation (%)

Gross Profit YoY VariationOperating Income YoY VariationNet Income YoY Variation
0250M500M750M1B1B2B2B2BQ1 2022Q4 2024Q1 2025Q2 2025Q3 2025

Price-to-Earning Ratio

P/E Ratio
-3-2-2-2-1-0001Q1 2022Q4 2024Q1 2025Q2 2025Q3 2025

Income Breakdown

Rule Of 40 (EBITDA)Rule Of 40 (FCF)
0500M1B2B2B2B3B4B4BQ1 2022Q4 2024Q1 2025Q2 2025Q3 2025

Per Share Metrics

Operating IncomeInterest IncomeTotal Other Income Expenses NetNet Income
0625B1T2T2T3T4T4T5TQ1 2022Q4 2024Q1 2025Q2 2025Q3 2025

Expense Ratios

Revenue Per ShareNet Income Per ShareOperating Cash Flow Per Share
038K75K112K150K188K225K262K300KQ1 2022Q4 2024Q1 2025Q2 2025Q3 2025
💰 Cash Flow Statement

Operating Cash Flow

Research And Ddevelopement To RevenueCapex To RevenueStock Based Compensation To Revenue
048111519222630Q1 2022Q4 2024Q1 2025Q2 2025Q3 2025

Free Cash Flow

Cash Flow to Debt Ratio

Cash At End Of Period
0250B500B750B1T1T2T2T2TQ1 2022Q4 2024Q1 2025Q2 2025Q3 2025
🏦 Balance Sheet
📈 Key Metrics